{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:11:52Z","timestamp":1761966712995,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.fertnstert.2011.06.073","type":"journal-article","created":{"date-parts":[[2011,8,30]],"date-time":"2011-08-30T17:39:40Z","timestamp":1314725980000},"page":"605-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A randomized controlled trial of NuvaRing versus combined oral contraceptive pills for pretreatment in\u00a0in\u00a0vitro fertilization cycles"],"prefix":"10.1016","volume":"96","clinical-trial-number":[{"clinical-trial-number":"nct01298128","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kimberly E.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munirah","family":"Alhajri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2011.06.073_bib1","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/12.11.2359","article-title":"Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients","volume":"12","author":"Damario","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/humrep\/del340","article-title":"Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol","volume":"22","author":"Cedrin-Durnerin","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10815-007-9189-7","article-title":"The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome","volume":"25","author":"Pinkas","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-199512020-00002","article-title":"The combined oral contraceptive. Risks and adverse effects in perspective","volume":"12","author":"Bagshaw","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib5","first-page":"412","article-title":"Side effects of oral contraceptives in the first treatment cycle [in German]","volume":"141","author":"Feichtinger","year":"1991","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":"Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mob.2002.121103","article-title":"Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel\/ethinyl estradiol","volume":"186","author":"Bjarnadottir","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2011.06.073_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13625187.2002.11949331","article-title":"Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing","volume":"7","author":"Roumen","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib10","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/humrep\/17.10.2594","article-title":"Ovarian function with a novel combined contraceptive vaginal ring","volume":"17","author":"Mulders","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.06.073_bib11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0015-0282(01)01689-2","article-title":"Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition","volume":"75","author":"Mulders","year":"2001","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.fertnstert.2011.06.073_bib12","first-page":"CD006109","article-title":"Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques","author":"Smulders","year":"2010","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028211010909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028211010909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:52:42Z","timestamp":1758009162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028211010909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0015028211010909"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2011.06.073","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled trial of NuvaRing versus combined oral contraceptive pills for pretreatment in\u00a0in\u00a0vitro fertilization cycles","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2011.06.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}